Oral Procysteine in HIV Infected Patients

Lietman, Paul S.

Abstract

This is a double-blind, randomized, placebo-controlled Phase 1 safety, tolerance, pharmacokinetic and biological efficacy study of Procysteine in HIV-infected individuals. Asymptomatic HIV-infected subjects with CD4 counts greater than 400/mm3 are being studied.

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Center for Research Resources (NCRR)
• Type: General Clinical Research Centers Program (M01)
• Project #: 5M01RR000035-33
• Application #: 3783632
• Support Year: 33
• Fiscal Year: 1993

Institution

• Name: Johns Hopkins University
• DUNS #: 045911138
• City: Baltimore
• State: MD
• Country: United States
• Zip Code: 21218

Publications

Kullmann, F Aura; Katofiasc, M; Thor, K B et al. (2017) Pharmacodynamic evaluation of Lys5, MeLeu9, Nle10-NKA(4-10) prokinetic effects on bladder and colon activity in acute spinal cord transected and spinally intact rats. Naunyn Schmiedebergs Arch Pharmacol 390:163-173

Mercadante, Courtney J; Herrera, Carolina; Pettiglio, Michael A et al. (2016) The effect of high dose oral manganese exposure on copper, iron and zinc levels in rats. Biometals 29:417-22

Doria-Rose, V Paul; Marcus, Pamela M; Miller, Anthony B et al. (2010) Does the source of death information affect cancer screening efficacy results? A study of the use of mortality review versus death certificates in four randomized trials. Clin Trials 7:69-77

Doria-Rose, V Paul; Marcus, Pamela M; Szabo, Eva et al. (2009) Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study. Cancer 115:5007-17

Holbrook, Janet T; Jabs, Douglas A; Weinberg, David V et al. (2003) Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before widespread availability of highly active antiretroviral therapy. Arch Ophthalmol 121:99-107

Martin, B K; Kaplan Gilpin, A M; Jabs, D A et al. (2001) Reliability, validity, and responsiveness of general and disease-specific quality of life measures in a clinical trial for cytomegalovirus retinitis. J Clin Epidemiol 54:376-86

Becker, D M; Tuggle, M B; Prentice, M F (2001) Building a gateway to promote cardiovascular health research in African American communities: lessons and findings from the field. Am J Med Sci 322:276-81

Holbrook, J T; Meinert, C L; Jabs, D A et al. (2001) Patient notification and follow-up after suspension of treatment protocols. experience from four clinical trials of treatments for AIDS-related CMV retinitis. Control Clin Trials 22:62-8

Kral, B G; Becker, L C; Yook, R M et al. (2001) Racial differences in low-density lipoprotein particle size in families at high risk for premature coronary heart disease. Ethn Dis 11:325-37

Becker, D M; Tuggle, M B; Prentice, M F (2001) Building a gateway to promote cardiovascular health research in African-American communities: lessons and findings from the field. Am J Med Sci 322:288-93